Firefly Neuroscience, Inc.
AIFF
$2.65
$0.0010.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -455.24% | -600.69% | -301.84% | -217.31% | -- |
| Total Depreciation and Amortization | 575.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,671.59% | 5,230.00% | 1,185.76% | 930.42% | -- |
| Change in Net Operating Assets | -708.90% | 75.28% | 227.21% | -725.76% | -- |
| Cash from Operations | -136.40% | -125.51% | -183.38% | -157.66% | -- |
| Capital Expenditure | -60.94% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 87.22% | 61.70% | 14.77% | -- | -- |
| Cash from Investing | -264.47% | 31.72% | -23.58% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 248.82% | 191.48% | -6.44% | 1,986.16% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -35.72% | -54.86% | -60.03% | -60.03% | -- |
| Repurchase of Preferred Stock | -0.25% | 60.03% | 60.03% | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 283.73% | 193.81% | 35.67% | 139.73% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50,445.45% | 414.44% | -115.97% | -46.25% | -- |